000 01412 a2200421 4500
005 20250517104051.0
264 0 _c20180130
008 201801s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.10440
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCalvo, Jennifer A
245 0 0 _aParp1 protects against Aag-dependent alkylation-induced nephrotoxicity in a sex-dependent manner.
_h[electronic resource]
260 _bOncotarget
_cJul 2016
300 _a44950-44965 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlkylation
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Alkylating
_xadverse effects
650 0 4 _aDNA Damage
_xdrug effects
650 0 4 _aDNA Glycosylases
_xmetabolism
650 0 4 _aDNA Repair
_xdrug effects
650 0 4 _aFemale
650 0 4 _aKidney
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aPoly (ADP-Ribose) Polymerase-1
_xmetabolism
650 0 4 _aSex Characteristics
700 1 _aAllocca, Mariacarmela
700 1 _aFake, Kimberly R
700 1 _aMuthupalani, Sureshkumar
700 1 _aCorrigan, Joshua J
700 1 _aBronson, Roderick T
700 1 _aSamson, Leona D
773 0 _tOncotarget
_gvol. 7
_gno. 29
_gp. 44950-44965
856 4 0 _uhttps://doi.org/10.18632/oncotarget.10440
_zAvailable from publisher's website
999 _c26203743
_d26203743